We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our Privacy Policy.
Yes, I accept
Menu
Search Opener
Vienna, Austria

ESTRO 2025

Session

Gynaecology
Digital Poster
Brachytherapy
Optimizing quality of life in cervical cancer survivors: A comparative study of the vaginal doses delivered with three HDR brachytherapy applicators
Salwa Fathy, Saudi Arabia
E25-78
Technique, experience and feasibility of hyaluronic acid rectovaginal spacers in MRI-guided gynecological cancer brachytherapy: a prospective study
Carminia Lapuz, Australia
E25-822
Assessment of fatigue and quality of life in patients treated for cervical cancer during brachytherapy
Rachida Laraichi, Morocco
E25-902
Evaluation of the impact of European guidelines on local control of locally advanced cervical cancer: a single-center retrospective study
Benjamin Cavallier, France
E25-927
An analysis of tandem-ovoid versus tandem-ring applicators: Can dosimetric differences influence applicator selection for intracavitary brachytherapy?
Siddharth Vats, India
E25-1323
Can the Second Daily Interventional Radiotherapy Fraction Be Planned Using the First Fraction's Treatment Plan?
Valentina Lancellotta, Italy
E25-1379
Evaluating feasibility of modern external beam radiotherapy as an alternative to brachytherapy in endometrial cancer treatment: a systematic review
Costanza Maria Donati, Italy
E25-1398
Single-dose intrathecal morphine in peri-procedural analgesia improves patient experience in MRI-guided adaptive brachytherapy for cervical cancer
Philip Yuguang Wu, Hong Kong (SAR) China
E25-1573
Feasibility of Centralizing MR-Guided Brachytherapy for Locally Advanced Cervical Cancer in Austria
Johannes Knoth, Austria
E25-1595
Electronic brachytherapy in the complex treatment of locally advanced cervical cancer
Desislava Hitova - Topkarova, Bulgaria
E25-1625
MR-Guided Adaptive Brachytherapy using Geneva Applicator with or without Needle Loading in Locally Advanced Cancer Cervix - A Dosimetry Analysis
Satyajit Pradhan, India
E25-1753
Feasibility and clinical results of brachytherapy for cervical cancer with distal parametrial involvement: experience of a French institute
Camille Roukoz, France
E25-394
Dosimetric comparison of brachytherapy and MRLinac boost for locally advanced cervical cancer
Renske van Noortwijk, The Netherlands
E25-1844
Feasibility of Electronic Brachytherapy in Cervical Cancer: A Dosimetric Analysis of Early Stage Patients
Sergio Lozares, Spain
E25-2031
Validating BRIGHT for the semi-automated brachytherapy treatment planning of cervical cancer
Tanja Alderliesten, The Netherlands
E25-2064
safety and efficacy of shortened high-dose-rate brachytherapy duration on outcomes in locally advanced cervical cancer: randomized clinical trial
Fatemeh Jafari, Iran Islamic Republic of
E25-2150
The impact of uterine position during brachytherapy on treatment outcomes in patients with cervical cancer
Ecem Yigit, Turkey
E25-2268
MRI-guided brachytherapy for cervical cancer - is 3 or 4 fractions best?
Clare Taylor, United Kingdom
E25-2598
Clinical outcomes of weekly versus biweekly interstitial and intracavitary brachytherapy for locally advanced cervical cancer
Paramintra Chitmanee, Thailand
E25-2660
Can Brachytherapy dose be safely de-escalated in selected patients of locally advanced cervical cancer in the era of IGABT?
Bhavana Rai, India
E25-2940
How to deal with needles: is there a right number of needles in interstitial brachytherapy for cervical cancer?
Beatrice Anghel, Romania
E25-2966
Integrating functional MR for target volume delineation in Image guided brachytherapy of Ca Cervix
Ankita mehta, India
E25-3239
Chronic Fistula Following Radiochemotherapy and Image Guided Adaptative Brachytherapy for Locally Advanced Cervical Cancer FIGO IIIC
Gregoire Laurent Delanghe, France
E25-3364
Dosimetric impact of translational and rotational applicator displacement on intracavitary/interstitial brachytherapy for cervical cancer
Natalie Kar Wei Yip, Hong Kong (SAR) China
E25-399
Variations in brachytherapy dose distribution for locally advanced cervical cancer: a dose gradient analysis
Mauro Iori, Italy
E25-3418
Outcomes in Locally Advanced Cervical Cancer FIGO IIIC treated by Radiochemotherapy and image guided adaptive Brachytherapy in pre immunotherapy era.
ABEL CORDOBA , France
E25-3422
Dose accumulation for gynecological reirradiation: Systematic review of methods and evidence for prepilot of decision tree in RetroCOSMOS study
Yvette Seppenwoolde, The Netherlands
E25-3437
Change of practice in MR-guided adaptive brachytherapy for cervical cancer by a multiparametric dose prescription protocol: From EMBRACEI to EMBRACEII
Nicole Nesvacil & Cyrus Chargari, Austria
E25-3489
A night's experience of brachytherapy with applicator in place
imane lahlali, Morocco
E25-3746
Implementing Image-Guided Brachytherapy For Cervical Cancer in Resource-Limited Settings:A Multicentre Workflow Impact Analysis from 14 Global Centres
Sandra Ndarukwa, Austria
E25-3757
Vaginal anatomical and physiological changes after external radiotherapy and brachytherapy.
imane lahlali, Morocco
E25-3793
Feasibility of CT-based target delineation and its influence in the intracavitary brachytherapy planning in cervical cancer.
SHAHA SHEIK ABDULLA M, India
E25-4053
Long-term outcomes of image-guided adaptive brachytherapy in cervical cancer: Analysis of a Chilean cohort
Gabriel Lazcano Álvarez, Chile
E25-4075
Interfraction dosimetric evaluation method in image-guided-adaptive brachytherapy in locally advanced cervical cancer.
Sara Montemuiño, Spain
E25-4211
IMPACT OF VAGINAL DOSE ON SEXUAL QUALITY OF LIFE AND VAGINAL SYMPTOMS IN PATIENTS WITH LOCALLY ADVANCED CERVICAL CANCER (LACC).
Benjamin Cavallier, France
E25-429
The impact of AI driven templates in brachytherapy practice
Maria Timpea, Romania
E25-4352
Analysis of TRAK/Volume Metrics and Dose Coverage in Interstitial Brachytherapy for Cervical and Uterine Cancers
Alek Rapchak, USA
E25-4510
Correlation of Indirect Ratio of Excess dose (iRex) on Late GI Tox in Cervix IGABT: A Pooled Data from single-center EMBRACE II and HYPOCx-iRex study
Tissana Prasartseree, Thailand
E25-4542
Clinical Impact of Image-Guided Adaptive Brachytherapy in Locally Advanced Cervical Cancer: 5-Year Experience from a Developing Country
Elena Manea, Romania
E25-4570
3D printed applicators in HDR interstitial and surface brachytherapy
Daniel Hernandez Martinez, Mexico
E25-4631
Computed Tomography–Guided Needle Insertion in Interstitial Brachytherapy for Locally Advanced Cervical Cancer
Talha Maqsood, Pakistan
E25-459
Response Adapted Precise and Individualized Dose in favorable risk cervical cancer (RAPID - Cervix): A preinitiation feasibility study.
Prachi Mittal, India
E25-599
Deep learning-based brachytherapy dose prediction and further optimization
Xianliang Wang, China
E25-680
Evaluating Dosimetric Stability and feasibility of Single-Application HDR Brachytherapy for Cervical Cancer
Sophie RENARD, France
E25-711
Experience on the use of the Venezia® applicator for brachytherapy of vaginal tumours in 19 patients
Sophie RENARD, France
E25-763